Skip to content
Colorectal Cancer Clinical Trials

Minneapolis, Minnesota

Colorectal cancer clinical trials in Minneapolis, MN

24 colorectal cancer studies are recruiting participants at sites in Minneapolis as of November 16, 2026, according to ClinicalTrials.gov. Colorectal Cancer Clinical Trials can help you understand your options and connect with a study team.

Call (888) 385-9581
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Minneapolis at a glance

  • 24 studies are recruiting at a site in Minneapolis.
  • By phase: Phase 1 (2), Phase 1/2 (6), Phase 2 (2), Phase 2/3 (1), Phase 3 (4), No phase (4), Observational (5). Studies of devices and behavioral approaches have no phase.
  • By sponsor: university, hospital or other (15), industry (8), government (1).
  • Most recent update to one of these records: November 16, 2026.

Studies recruiting in Minneapolis

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    ECOG-ACRIN Cancer Research Group
    Study site
    University of Minnesota/Masonic Cancer Center
    Registry record
    NCT05863195 · updated
  2. SumMET: Study of [225Ac]Ac-FL-261 in Participants With Solid Tumors Overexpressing c-MET

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Full-Life Technologies UK Limited
    Study site
    Full-Life Technologies Investigational Site
    Registry record
    NCT07873450 · updated
  3. The Vanguard Study: Testing a New Way to Screen for Cancer

    • No phase
    • Ages 45 to 75
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Study site
    Minneapolis VA Medical Center
    Registry record
    NCT06995898 · updated
  4. Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    SWOG Cancer Research Network
    Study sites
    Abbott-Northwestern Hospital · Hennepin County Medical Center
    Registry record
    NCT07018869 · updated
  5. Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer

    • Observational
    • Ages 60 and older
    • All sexes
    Sponsor
    Wake Forest University Health Sciences
    Study site
    Abbott-Northwestern Hospital
    Registry record
    NCT03998202 · updated
  6. Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Summit Therapeutics
    Registry record
    NCT07228832 · updated
  7. Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

    • No phase
    • Ages 45 to 70
    • All sexes
    Sponsor
    NRG Oncology
    Study sites
    Abbott-Northwestern Hospital · Hennepin County Medical Center · Minneapolis VA Medical Center
    Registry record
    NCT05080673 · updated
  8. Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    NRG Oncology
    Study sites
    Abbott-Northwestern Hospital · Hennepin County Medical Center
    Registry record
    NCT05174169 · updated
  9. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    • Observational
    • Ages 40 to 75
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study sites
    Abbott-Northwestern Hospital · Hennepin County Medical Center
    Registry record
    NCT05334069 · updated
  10. Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Wake Forest University Health Sciences
    Study sites
    Abbott-Northwestern Hospital · Hennepin County Medical Center
    Registry record
    NCT06418204 · updated
  11. Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study sites
    Abbott-Northwestern Hospital · Hennepin County Medical Center
    Registry record
    NCT07283939 · updated
  12. Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study site
    University of Minnesota/Masonic Cancer Center
    Registry record
    NCT05673148 · updated
  13. Family Communications After Genetic Testing

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Study sites
    Abbott-Northwestern Hospital · Hennepin County Medical Center
    Registry record
    NCT07143487 · updated
  14. A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Daiichi Sankyo
    Study site
    M Health Fairview University of Minnesota Medical Center
    Registry record
    NCT06330064 · updated
  15. Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Institut de Recherches Internationales Servier
    Study site
    Masonic Cancer Center University of Minnesota
    Registry record
    NCT05786924 · updated
  16. A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    AbbVie
    Study site
    Scri Minnesota Oncology Hematology, P.A. /ID# 275149
    Registry record
    NCT07023289 · updated
  17. FOG-001 in Locally Advanced or Metastatic Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Parabilis Medicines, Inc.
    Study site
    M Health Fairview University of Minnesota Medical Center
    Registry record
    NCT05919264 · updated
  18. PRE-ISPY Phase I/II Oncology Platform Program

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    QuantumLeap Healthcare Collaborative
    Study site
    University of Minnesota Masonic Cancer Center
    Registry record
    NCT05868226 · updated
  19. FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Fate Therapeutics
    Study site
    University of Minnesota Masonic Cancer Center
    Registry record
    NCT07216105 · updated
  20. Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

    • Phase 1/2
    • From 12 months, up to 30 years
    • All sexes
    Sponsor
    Children's Oncology Group
    Study site
    University of Minnesota/Masonic Cancer Center
    Registry record
    NCT04851119 · updated
  21. Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    AbbVie
    Study site
    M Health Fairview University of Minnesota Medical Center - East Bank /ID# 276200
    Registry record
    NCT05005403 · updated
  22. Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Michigan Rogel Cancer Center
    Study site
    University of Minnesota
    Registry record
    NCT00843375 · updated
  23. Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    GlaxoSmithKline
    Study site
    GSK Investigational Site
    Registry record
    NCT05855200 · updated
  24. LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    University of Rochester
    Study sites
    Abbott-Northwestern Hospital · Hennepin County Medical Center
    Registry record
    NCT06073431 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Minneapolis, MN on ClinicalTrials.gov.

Ask about studies near Minneapolis

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Minnesota

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 385-9581

or send a short form

How should we reach you?

Call